12:00 AM
 | 
Jul 01, 2013
 |  BC Week In Review  |  Company News  |  Other News

AmVac infectious news

AmVac received two five-year grants to develop vaccines under the EU's Framework Programme 7 (FP7). The projects are part of initiatives that include other companies...

Read the full 104 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >